Richard Schwartz, PhD, is the founder of the Internal Family Systems (IFS) therapy model. He now serves on the Faculty of the Department of Psychiatry at Harvard Medical School and is a Senior Fellow at the Meadows treatment centre in Arizona. In 2000, he founded the Center for Self Leadership (now IFS Institute), which offers three levels of training and workshops in IFS for professionals and the general public, both in this U.S. and abroad. A featured speaker for national professional organizations, Dr. Schwartz has published many books and over fifty articles about IFS.
Gabor Maté, MD, is a renowned speaker and bestselling author. He is highly sought after for his expertise on a range of topics including trauma treatment, addiction, stress, and childhood development. As an author, Dr. Maté has written several bestselling books including the award-winning In the Realm of Hungry Ghosts: Close Encounters with Addiction; When the Body Says No; The Cost of Hidden Stress; and Scattered Minds: A New Look at the Origins and Healing of Attention Deficit Disorder, as well as the newly released The Myth of Normal.
Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders.
Dr. Ingmar Gorman is a co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike.
Seema Desai, MD, is a board-certified child, adolescent, and adult psychiatrist with a clinical interest in the intersection of spirituality and psychiatry. She is currently a study therapist in a MAPS trial examining the effects of MDMA for the treatment of PTSD. She offers psychopharmacology treatment and ketamine-assisted psychotherapy in her private practice.
Jeffrey Guss, MD, is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy, addictions, and psychedelic therapy. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine's study on psilocybin-assisted psychotherapy in the treatment of cancer-related existential distress, and is currently a study therapist on studies of Psilocybin-Assisted treatment of Major Depressive Disorder and MDMA-Assisted Psychotherapy for PTSD.
Matthew Johnson, PhD, is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world's most widely published experts on psychedelics. He has published research on psychedelics and mystical experiences, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received, as principal investigator, the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in the treatment of tobacco addiction. He is also known for his expertise in behavioural economics, addiction, sexual risk behaviour, and research with a wide variety of drug classes.
Victor Cabral, MSW, LSW, CCTP-I, is the Founder of Dreamers of the Day LLC. and serves as the Director of Policy and Regulatory Affairs for Fluence International Inc., a company that provides evidence-based training in psychedelic therapy and integration services to clinicians across the globe.
Phil Wolfson, MD, is president and CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Training Center. Phil's book, The Ketamine Papers, is the seminal work in the burgeoning ketamine arena. He is principal investigator for the MAPS-sponsored Phase 2, the FDA-approved 18-person study of MDMA-Assisted Psychotherapy for individuals with significant anxiety due to life-threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine-Assisted Psychotherapy.
Monnica T. Williams, PhD, is a board-certified licensed clinical psychologist who was named one of the top 25 thought leaders in PTSD by PTSD Journal. Her work has been featured in several major media outlets, including NPR, Huffington Post, CNN, and the New York Times. Dr. Williams has published over 100 book chapters and peer-reviewed articles focused on trauma and other anxiety-related disorders and cultural differences. She is currently an Associate Professor at the University of Ottawa in the School of Psychology, where she is the Canada Research Chair for Mental Health Disparities. She is also Clinical Director of the Behavioral Wellness Clinic in Connecticut, where she provides supervision and training to clinicians for empirically-supported treatments.
